The impact of centralized coronary stent procurement program on acute myocardial infarction treatments: evidence from China.

ABSTRACT:

Background

The advent of coronary stents has resulted in many more many lives being saved from acute myocardial infarction (AMI). However, the high price associated with this method of treatment also imposes a heavy economic burden on healthcare systems. As a country making significant use of coronary stents, in 2021, China introduced a program around this method of treatment grounded in centralized procurement and it is the focus of this paper to assess the impact of this policy on AMI treatments.

Methods

The patients with AMI are selected as the study group, and the patients with pre-cerebral vascular stenosis are selected as the control group, and individual-level medical insurance settlement data are collected from the years 2018, 2019, and 2021. Differences-in-differenc

SUBMITTER: Jian W 

PROVIDER: S-EPMC10720903 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature